NEW YORK, Feb 27 – Illumina of San Diego said Tuesday it had penned a deal with Chevron Research and Technology to study ways Illumina’s fiber-optic BeadArray microarray technology could be used to detect compounds in chemical plant operations.

Chevron, which is funding the study, expects to complete the research by early 2002. Chevron previously invested in Illumina through its venture capital group.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.